Physician profile
Robert Davis
NPI 1255440228
$3,299.94
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,819 · 2020: $272 · 2021: $441 · 2022: $768.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $808.69 | 2019-2021 | |
| Genzyme Corporation | $436.92 | 2019-2022 | |
| Celgene Corporation | $415.40 | 2019 | |
| Janssen Biotech, INC. | $343.31 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $301.19 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $176.77 | 2019-2022 | |
| Lilly USA, LLC | $161.51 | 2019-2022 | |
| Pfizer INC. | $156.06 | 2019-2022 | |
| Ucb, INC. | $126.47 | 2019-2022 | |
| Galderma Laboratories, L.P. | $112.15 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $74.42 | 2019-2020 | |
| Amgen INC. | $59.57 | 2020-2022 | |
| Leo Pharma INC. | $40.00 | 2022 | |
| Dermira, INC. | $23.07 | 2019 | |
| Sun Pharmaceutical Industries INC. | $19.46 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $17.40 | 2021 | |
| Allergan, INC. | $14.62 | 2019 | |
| Mentor Worldwide LLC | $12.93 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.